Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
astrazeneca
2
×
biotech
2
×
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
2
×
fda
indiana blog main
indiana top stories
ipo
life sciences
multiple myeloma
national
national blog main
national top stories
2
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
antibiotics
arvinas
What
ipo
2
×
acquisitions
announced
bio
biotechs
ceo
chose
close
collabs
company
covid
daniel
deal
device
firms
gilead
gilead’s
help
introduce
ipos
life
make
medical
medicines
month
open
o’day
plans
q
quarter
roundup
science
sciences
transformative
way
week
window
years
Language
unset
Current search:
astrazeneca
×
biotech
×
ipo
×
" national top stories "
×
photo
×
" detroit top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way